The impact of obesity on early mortality after coronary artery bypass grafting

  • Nada Čemerlić-Adjić Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Katica Pavlović Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Marija Jevtić Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia; Institute of Public Health of Vojvodina, Novi Sad, Serbia
  • Radmila Velicki Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia; Institute of Public Health of Vojvodina, Novi Sad, Serbia
  • Saša Kostovski Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia
  • Lazar Velicki Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Keywords: obesity, body mass index, myocardial revascularization, postoperative period, mortality,

Abstract


Background/Aim. It had been suggested that elevated body mass index (BMI) is a beneficial and preventive factor when it comes to the outcome for patients undergoing coronary artery bypass grafting (CABG). At the same time, obesity is strongly associated with coronary artery disease development. The aim of this study was to determine the significance of the obesity paradox in patients referred for CABG and to examine if a relationship exists between obesity and early coronary surgery outcome. Methods. This study comparised 791 patients who had undergone isolated CABG over one year period (year 2010). The average age of patients was 62.33 ± 8.12 years and involved 568 (71.8%) male and 223 (28.2%) female patients, while the mean logistic EuroSCORE was 3.42%. The patients were categorized into three distinct groups based on their BMI: I – BMI < 24.9 kg/m2; II – BMI 25–30 kg/m2; III – BMI > 30 kg/m2. Regression analysis was conducted to determine whether BMI was an independent predictor of early mortality after CABG. Results. The majority of the cohort could be categorized as overweight (49%) or obese (30%). There was no association between BMI and gender (p = 0.398). The overall early mortality was 2.15% (1.85% in the group I, 2.06% in the group II and 2.51% in the group III; p = 0.869). Univariate analysis showed that obesity cannot be regarded as an independent risk factor for early mortality following CABG (odds ratio 1.021, 95% confidence interval 0.910–1.145, p = 0.724). Duration of in-hospital period following the surgery was comparable within the BMI groups (p = 0.502). Conclusion. Compared to non-obese patients, overweight and obese individuals have similar early mortality rate following CABG. This study can substantiate the presence of obesity paradox only in terms that elevated BMI patients have comparable outcome with non-obese. Further research is needed to delineate potential underlying mechanisms that set off obesity to protective factor for coronary surgery.

References

Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53(21): 1925−32.

Dorner TE, Rieder A. Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 2012; 155(1): 56−65.

Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med 2008; 120(2): 34−41.

Gruberg L, Mercado N, Milo S, Boersma E, Disco C, van Es GA, et al. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II? Am J Cardiol 2005; 95(4): 439−44.

Lavie CJ, De Schutter A, Patel D, Artham SM, Milani RV. Body composition and coronary heart disease mortality – an obesity or a lean paradox? Mayo Clin Proc 2011; 86(9): 857−64.

Yap CH, Zimmet A, Mohajeri M, Yii M. Effect of obesity on early morbidity and mortality following cardiac surgery. Heart Lung Circ 2007; 16(1): 31−6.

National Institutes of Health.Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. Obes Res 1998; 6 Suppl 2: 51S−209S.

Lancefield T, Clark DJ, Andrianopoulos N, Brennan AL, Reid CM, Johns J, et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv 2010; 3(6): 660−8.

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341(15): 1097−105.

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359(20): 2105−20.

Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997; 96(9): 3248−50.

Kastorini CM, Milionis HJ, Goudevenos JA, Panagiotakos DB. Mediterranean diet and coronary heart disease: is obesity a link? - A systematic review. Nutr Metab Cardiovasc Dis 2010; 20(7): 536−51.

Sundell J. Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanisms. Diabetes Obes Metab 2005; 7(1): 9−20.

Lavie CJ, Milani RV. Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol 2003; 42(4): 677−9.

Engel AM, McDonough S, Smith JM. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 2009; 88(6): 1793−800.

Galal W, van Domburg RT, Feringa HH, Schouten O, Elhendy A, Bax JJ, et al. Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol 2007; 99(11): 1485−90.

Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring) 2008; 16(2): 442−50.

Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368(9536): 666−78.

Shirzad M, Karimi A, Armadi SH, Marzban M, Abbasi K, Alinejad B, et al. Effects of body mass index on early outcome of coronary artery bypass surgery. Minerva Chir 2009; 64(1): 17−23.

Artham SM, Lavie CJ, Milani RV, Ventura HO. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J 2009; 9(3): 124−32.

Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003; 24(9): 881−2.

Lopez-Jimenez F, Cortes-Bergoderi M. Update: systemic diseases and the cardiovascular system (i): obesity and the heart. Rev Esp Cardiol 2011; 64(2): 140−9.

Wigfield CH, Lindsey JD, Munoz A, Chopra PS, Edwards NM, Love RB. Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI > or = 40. Eur J Cardiothorac Surg 2006; 29(4): 434−40.

Kuduvalli M, Grayson AD, Oo AY, Fabri BM, Rashid A. The effect of obesity on mid-term survival following coronary artery bypass surgery. Eur J Cardiothorac Surg 2003; 23(3): 368−73.

Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006; 26(5): 968−76.

Rockx MA, Fox SA, Stitt LW, Lehnhardt KR, McKenzie FN, Quanty MA, et al. Is obesity a predictor of mortality, morbidity and readmission after cardiac surgery? Can J Surg 2004; 47(1): 34−8.

Rahmanian PB, Adams DH, Castillo JG, Chikwe J, Bodian CA, Filsoufi F. Impact of body mass index on early outcome and late survival in patients undergoing coronary artery bypass grafting or valve surgery or both. Am J Cardiol 2007; 100(11): 1702−8.

Florath I, Albert AA, Rosendahl UP, Hassanein WM, Bauer S, Ennker IC, et al. Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement? J Heart Valve Dis 2006; 15(3): 336−44.

Prabhakar G, Haan CK, Peterson ED, Coombs LP, Cruzzavala JL, Murray GF. The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: a study from the Society of Thoracic Surgeons' database. Ann Thorac Surg 2002; 74(4): 1125−30.

Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis. Ann Thorac Surg 2005; 79(6): 1976−86.

Reeves BC, Ascione R, Chamberlain MH, Angelini GD. Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 2003; 42(4): 668−76.

Gurm HS, Whitlow PL, Kip KE. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 2002; 39(5): 834−40.

Mihajlovic B, Nicin S, Cemerlic-Adjic N, Pavlovic K, Dodic S, Velicki L, et al. Trends of risk factors in coronary surgery. Srp Arh Celok Lek 2010; 138(9−10): 570−6.

Mihajlovic B, Nicin S, Kovacevic P, Susak S, Velicki L, Kovacevic D, et al. Evaluation of results in coronary surgery using EuroSCORE. Srp Arh Celok Lek 2011; 139(1−2): 25−9.

Todd MM, Lavie CJ, White CJ. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr 2008; 3(3): 162−7.

Shirzad M, Karimi A, Dowlatshahi S, Ahmadi SH, Davoodi S, Marzban M, et al. Relationship between body mass index and left main disease: the obesity paradox. Arch Med Res 2009; 40(7): 618−24.

Published
2015/04/21
Section
Original Paper